Human medicines European public assessment report (EPAR): Wegovy, semaglutide, Date of authorisation: 06/01/2022, Revision: 20, Status: Authorised
New product information wording - extracts from PRAC recommendations on signals adopted at the 28 September-1 October 2026 PRAC
PRAC recommendations on signals adopted at the 28 September-1 October 2026 PRAC meeting
List of signals discussed at PRAC since September 2012
Human medicines European public assessment report (EPAR): Rezdiffra, resmetirom, Date of authorisation: 18/08/2025, Revision: 1, Status: Authorised
CHMP PROM minutes for the meeting on 15 June 2026
Human medicines European public assessment report (EPAR): Bavencio, avelumab, Date of authorisation: 18/09/2017, Revision: 24, Status: Authorised
CHMP PROM minutes for the meeting on 16 March 2026
CHMP PROM minutes for the meeting on 11 May 2026
Human medicines European public assessment report (EPAR): Pemetrexed medac, pemetrexed, Date of authorisation: 26/11/2015, Revision: 9, Status: Withdrawn